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Objective: The latest research suggests cells in the maculae flavae (MFe) are putative stem cells of the vocal fold mucosa
and the MFe are a candidate for a stem cell niche. Distribution and properties of label-retaining cells (LRCs) in the vocal fold
mucosa were investigated.
Study Design: Histologic analysis of the rat vocal folds.
Methods: Oral administration of bromodeoxyuridine (BrdU) was given to rats and the LRCs in the vocal fold mucosa
were observed by immunohistochemistry. Immunoreactivity to antibodies directed to BrdU, Ki67, cytokeratin, vimentin, glial
fibrillary acidic protein, desmin, Sox17, CD34, CD45, Type I collagen, and CD44 was studied. Extracellular matrices around
LRCs were observed by Alcian blue staining and hyaluronidase digestion study.
Results: LRCs were present in the MFe and were resting cells (G0-phase). They expressed epithelium, muscle, neural, and
mesenchymal cell–associated intermediate filament proteins, and an endodermal marker, indicating cells in the MFe are undif-
ferentiated and express proteins of all three germ layers. They expressed hematopoietic markers (CD34, CD45) and Type I col-
lagen, which are the major markers of bone marrow derived circulating fibrocytes. The hyaluronan concentration in the MFe
was high and the cells in the MFe expressed the surface hyaluronan receptor CD44, indicating that the MFe were a
hyaluronan-rich matrix.
Conclusion: LRCs reside in the MFe and MFe had a hyaluronan-rich matrix. The results of this study are consistent with
the hypothesis that the cells in the MFe are putative stem cells and the MFe are a candidate for a stem cell niche.
Key Words: label-retaining cells, hyaluronan-rich matrix, vocal fold, tissue stem cells, stem cell niche.
Level of Evidence: N/A
INTRODUCTION
Adult tissue-specific stem cells (tissue stem cells)
have the capacity to self-renew and generate functionally
differentiated cells that replenish lost cells throughout an
organism’s lifetime.1 In recent years, there have been
many reports on tissue stem cells and experimental
methods to detect them.
Label-retaining cell assay is one of the methods to
detect tissue stem cells and has been used in various
organs.2–4 BrdU (bromodeoxyuridine) is commonly used
to label a cell’s DNA. BrdU labeling is diluted and lost
during cell division, consequently, stem cells retain label-
ing because of their slow cell cycle. Label-retaining cell
assay is experimentally used to determine putative stem
cells.
As described in detail previously,5 human maculae
flavae located at both ends of the vocal fold mucosa are
inferred to be involved in the metabolism of extracellular
matrices, which are essential for the viscoelastic proper-
ties of the lamina propria of the human vocal fold, and to
be responsible for maintaining the characteristic layered
structure of the human vocal fold mucosa. As described in
detail previously,6 human maculae flavae are considered
to be an important structure in the growth, development
and aging of the human vocal fold mucosa.
The previous research shows,7–11 there is growing evi-
dence to suggest that the cells in the maculae flavae are
putative stem cells or progenitor cells of the vocal fold
mucosa, and that the maculae flavae are a candidate for a
stem cell niche.
The purpose of this study is to investigate the distri-
bution and the properties of label-retaining cells, and
microenvironment around the label-retaining cells in the
vocal fold mucosa.
MATERIALS AND METHODS
Experimental Animals
All animal experiments were performed with the approval
of the Kurume University Animal Care and Treatment Commit-
tee (Permit Number. 2017-200). Twelve male 3-week-old
Sprague-Dawley rats (Japan SLC, Shizuoka, Japan) were used
for this experiment. They were caged individually with free
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access to standard laboratory chow and tap water. Individual
cage sizes were 272 millimeters (width) x 434 millimeters (depth)
x 203 millimeters (height). The rats health and behaviors were
monitored every day.
Label-Retaining Cell Assay
All rats were orally administered 1.0mg/mL bromodeoxyur-
idine (BrdU) (Sigma-Aldrich, St Louis, MO) dissolved in drinking
water for 7 consecutive days. The rat larynges were observed at
three separated intervals. Four rats were sacrificed each time at
1, 14, and 56 days after the 7 consecutive days of BrdU adminis-
trations and their larynges were harvested.
When rats were sacrificed, they were euthanized by isoflur-
ane and carbonic acid gas. Larynges were fixed in 10% neutral
formalin for 6 hours and preserved in 70% ethanol at room tem-
perature. Immunohistochemical staining was carried out to
detect label-retaining cells.
BrdU-positive cells in the maculae flavae, the staratified
squamous epithelium and the lamina propria of the vocal fold
mucosa were counted in 16 fields of vision each (50 μm x 50
μm) on a light microscope at 1, 14, and 56 days. The
average percentages of BrdU-positive cells were compared
statistically.
Immunohistochemistry
BrdU, Ki-67, cytokeratin, vimentin, glial fibrillary acidic
protein (GFAP), desmin, Sox17, CD44, CD34, CD45, Type I colla-
gen were histologically detected in the formalin-fixed and
paraffin-embedded tissue by immunohistochemistry, for which
a universal immune-enzyme polymer method staining kit
(Histofine Simple Stain MAX-PO, Nichirei, Tokyo, Japan) was
used. After being dehydrated in a graded concentration of etha-
nol and embedded in paraffin, all specimens were sectioned to a
thickness of 3 μm and mounted on glass slides. After deparaffini-
zation and hydration, slides with specimens were incubated at
99C in a target retrieval solution (DAKO, Glostrup, Denmark)
for 40 minutes. Then, endogenous peroxidase was blocked with
3% hydrogen peroxidase for 10 minutes and nonspecific binding
with serum free proteins (DAKO, Glostrup, Denmark) was per-
formed. The specimens were then incubated with monoclonal
mouse primary antibody at 4C overnight. Between all processes,
slides with specimens were rinsed with 0.1-mol/L phosphate-
buffered saline solution (PBS) at pH 7.4.
A 1:20 diluted monoclonal antibody against BrdU (DAKO,
Glostrup, Denmark, mouse monoclonal), a 1:100 against Ki-67
(Abcam, Cambridge, UK, ab16667, rabbit monoclonal), a 1:100
against cytokeratin (Novus biologicals, Abingdon, UK,
NBP2-29429, mouse monoclonal), a 1:100 against vimentin
(Abcam, Cambridge, UK, ab8978, mouse monoclonal), a 1:100
against GFAP (Abcam, Cambridge, UK, ab10062, mouse mono-
clonal), a 1:100 against desmin (Abcam, Cambridge, UK, ab6322,
mouse monoclonal), a 1:100 against Sox17 (Abcam, Cambridge,
UK, ab84990, mouse monoclonal), a 1:250 against CD44 (Abcam,
Cambridge, UK, ab157107, rabbit polyclonal), a 1:200 against
CD34 (Abcam, Cambridge, UK, ab81289, rabbit monoclonal), a
1:100 against CD45 (Abcam, Cambridge, UK, ab10558, rabbit
polyclonal), and a 1:500 against Type I collagen (Abcam plc.
Cambridge, UK, ab34710, rabbit polyclonal) were used.
After labeling with the universal immuno-enzyme polymer
method staining kit, a color reaction was developed with 3,3’-
diaminobenzidine tetrahydrochloride for 5 to 10 minutes at
room temperature. Immunoreactivity was examined by light
microscopy.
Fig. 1. BrdU-positive cells in the rat vocal fold mucosa. A: Macula flava at day 1 after BrdU administration. B: Macula flava at day 56 after
BrdU administration. C: Epithelium and lamina propria of the vocal fold mucosa at day 1 after BrdU administration. D: Epithelium and lamina
propria of the vocal fold mucosa at day 56 after BrdU administration. Cells in the maculae flavae retained BrdU for an long period, indicating
that they were label-retaining cells.
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Alcian Blue Staining and Hyaluronidase
Digestion Study
Alcian blue staining (pH 2.5) and hyarulonidase digestion
study were performed to detect hyaluronic acid. For the hyal-
uronidase digestion study, 12.5-mg bovine testes hyaluronidase
(Sigma, St Louis, MO) was diluted in 100 mL of PBS. The sec-
tions were incubated in the diluted hyaluronidase solution for
4 hours at 37C. The thin sections were subsequently stained
with Alcian blue (pH 2.5).
RESULTS
Distribution of Label-Retaining Cells in the
Vocal Fold Mucosa
At day 1 after BrdU administration for 7 consecutive
days, BrdU-positive cells were identified in basal to
superficial layer of the stratified squamous epithelium
(54.1 ± 10.3%, mean ± SD%), the lamina propria
(41.7 ± 11.6%) and the anterior and posterior maculae fla-
vae (44.8 ± 14.2%) of the vocal fold (Figs. 1 and 2).
At day 14 after BrdU administration, BrdU-positive
cells in the stratified squamous epithelium (18.8 ± 3.8%),
especially in the superficial layer, and the lamina propria
(18.8 ± 11.6%) had decreased compared day 1 (P < .01)
(Fig. 2). Some BrdU-positive cells remained in the basal
layer of the stratified squamous epithelium as well. How-
ever, BrdU-positive cells remained in the anterior and
posterior maculae flavae (41.4 ± 5.5%) (P < .01) (Fig. 2).
At day 56 after administration, the number of BrdU-
positive cells was very small in the basal layer of the
stratified squamous epithelium (2.4 ± 3.8%) and the lam-
ina propria (6.5 ± 6.5%). However, the number of BrdU-
positive cells remaining in the anterior and posterior
maculae flavae was high (33.3 ± 12.7%) (Fig. 1). The high
BrdU-positive cell ratio in the maculae flavae was main-
tained though day 56 (P < .01)(Fig. 2).
According to these results, label-retaining cells
resided in the maculae flavae of the vocal fold.
Cell Cycle of the Cells in the Maculae Flavae
Few Ki-67 positive cells were identified in the macu-
lae flavae (Fig. 3) indicating that the cells in the maculae
flavae are in the resting phase (G0 phase).
Intermediate Filaments of the Cells in the
Maculae Flavae
Cytokeratin, vimentin, GFAP, and desmin were
present in the cells in the macula flavae (Fig. 4),
Fig. 2. Mean percentage of BrdU-positive cells in each region of the vocal fold at three separated intervals (day 1, 14, 56). Epi = epithelium;
LP = lamina propria of the vocal fold mucosa; MF = maculae flavae. The percentage of BrdU-positive cells in the epithelium and lamina pro-
pria of the rat vocal fold mucosa decreased significantly by day 56. On the other hand, BrdU-positive cells in the rat maculae flavae was main-
tained throgh day 56.
Fig. 3. Ki67 positive cells in the rat vocal fold mucosa. A: Macula flava, B: epithelium and lamina propria of the vocal fold mucosa. Ki-67–
positive cells were identified in the basal layer of the stratified squamous epithelium and in the lamina propria of the vocal fold mucosa. Few
Ki-67–positive cells were identified in the maculae flavae.
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indicating that the cells expressed epithelium, muscle,
neural, and mesenchymal cell–associated intermediate
filaments and expressed proteins of the ectodermal and
mesodermal germ layers. In addition, cells in the
macula flavae expressed Sox17, an endodermal marker
(Fig. 4). These results suggest the cells in the maculae
flavae are undifferentiated and express proteins of all
three germ layers.
Fig. 4. Immunohistochemical staining of the cells in the maculae flavae of the rat vocal fold. Cytokeratin (A), desmin (B), glial fibrillary acidic protein
(C), vimentin (D), and Sox17 (E) immunoreactivity were present. The cells in the maculae flavae express proteins of all three germ layers.
Fig. 5. Macula flava of the rat vocal fold (A: Alcian blue staining, pH 2.5) (B: immunohistochemical staining of CD44). A large amount of the gly-
cosaminoglycan hyaluronan (light blue stained material) is situated around the cells in the macula flava and the cells expressed CD44, a cell
surface hyaluronan receptors, indicating the macula flava has a hyaluronan-rich matrix.
Fig. 6. Immunohistochemical staining of the cells in the macula flava of the rat vocal fold for major markers of bone marrow-derived circulating
fibrocytes. CD34 (A), CD45 (B), and Type I collagen (C) were expressed in the cells in the maculae flavae.
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Microenvironment Around the Cells in the
Maculae Flavae
The anterior and posterior maculae flavae were
strongly stained light blue with Alcian blue at pH 2.5
(Fig. 5A). The materials in the maculae flavae that were
strongly stained with Alcian blue at pH 2.5 were digested
by hyaluronidase. A great deal of hyaluronan was situ-
ated around the cells in the maculae flavae. CD44 cell
surface hyaluronan receptors were expressed in the cells
in the maculae flavae (Fig. 5B), indicating that the macu-
lae flavae were a hyaluronan-rich matrix.
Origin of the Cells in the Maculae Flavae
The cells in the maculae flavae expressed CD34
(hematopoietic progenitor cell marker), CD45 (leukocyte
common antigen) and type I collagen (Fig. 6), which are
the major makers of bone marrow derived circulating
fibrocytes.
DISCUSSION
As described in detail previously,1 adult tissue-specific
stem cells (tissue stem cells) have the capacity to self-renew
and generate functionally differentiated cells that replenish
lost cells throughout an organism’s lifetime. Tissue-specific
stem cells reside in a niche, whereby a complex microenvi-
ronment maintains their multipotency.
Label-retaining cell assay has been used in many
investigations to detect tissue stem cells and their
distribution.2–4
Label-Retaining Cell Assay
Adult tissue stem cells consistently retain labeled
DNA since stem cells divide more infrequently than other
cells. BrdU is an analogue of thymidine which incorpo-
rates into the cell’s DNA during in the S phase of mitosis.
In the present study, just after BrdU administration,
BrdU-positive cells were identified in the basal to superfi-
cial layer of the stratified squamous epithelium, the lam-
ina propria, and the maculae flavae of the vocal fold
mucosa. However, the high BrdU-positive cell ratio in the
maculae flavae was maintained through day 56. And
therefore, label-retaining cells resided in the anterior and
posterior maculae flavae.
Bonhoeffer et al. reported BrdU labeling could be
observed for up to five or six cell divisions in human lym-
phocytes.12 In addition, Adams et al. reported the dou-
bling time of fibroblasts in the human vocal fold in the
primary culture of passage two is 30 hours.13 And Savelli
et al. reported cells in the basal layer epithelium divide
every 30 hours under physiologic conditions.14 If cells in
the vocal fold mucosa retain BrdU labeling for up to five
or six cell division as lymphocytes do, BrdU labeling could
be observed for up to 7 or 8 days in a normal cell cycle.
In the present study, the cells in the maculae flavae
retained BrdU labeling at day 56 after BrdU administra-
tion, indicating the division cycles of the cells in the mac-
ulae flavae are slow and different from other cells in the
vocal fold mucosa. Consequently, the cells containing in
the anterior and posterior maculae flavae are label-
retaining cells.
Cell Cycle of Label-Retaining Cells in the Vocal
Fold Mucosa
Tissue stem cells are usually in the resting phase
(G0 phase) of the cell cycle in their stem cell niche. Ki-67
is a nuclear protein expressed during all active phases of
the cell cycle (G1, S, G2, and M phases).
In the present study, Ki-67-positive cells were
detected in the basal layer of the stratified squamous epi-
thelium and lamina propria. However, there were few Ki-
67-positive cells in the maculae flavae. This result sug-
gests the cells in the maculae flavae are in the resting
phase (G0 phase) in the cell cycle.
The label-retaining cells resided in the maculae fla-
vae and they were in the resting phase (G0 phase) of the
cell cycle. Consequently, these results are consistent with
the hypothesis that the cells in the maculae flavae are
putative stem cells of the vocal fold mucosa.
Cell Differentiation of the Cells in the Maculae
Flavae of the Vocal Fold Mucosa
As described in detail previously, intermediate fila-
ments are structural proteins of the cytoplasm and spe-
cific to cell type and differentiation.15 Because of the
tissue specificity of intermediate filaments, cells from dif-
ferent tissues can be distinguished on the basis of the
intermediate filament protein present.15
As described in detail previously, cytokeratin is a
structural protein expressed in the epithelial cells, vimen-
tin is a major subunit protein of the intermediate fila-
ments expressed in various kinds of mesenchymal cells,
GFAP is a member of the structural protein family specif-
ically expressed in glial cells, desmin is a structural pro-
tein of the intermediate filament specifically expressed in
muscle cells.15
In the present study, immunoreactivities with cyto-
keratin, vimentin, GFAP, and desmin were present in the
cells in the maculae flavae of the vocal fold mucosa. As a
result, the cells in the maculae flavae expressed
epithelium-associated, mesenchymal cell-associated, neu-
ral cell-associated, and muscle-associated proteins, indi-
cating these cells have the ability to differentiate to
ectoderm cells and mesoderm cells. In addition, Sox17, an
endodermal marker, was expressed in the cells in the
maculae flavae. Consequently, the cells in the maculae
flavae of the vocal fold mucosa expressed proteins of all
three germ layers. The expression of proteins of all three
germ layers suggests that the cells in the maculae flavae
of the vocal fold mucosa are undifferentiated cells and
have the ability of multipotency.
Vocal Fold Stellate Cells in the Maculae Flavae
of the Human Vocal Fold Mucosa
Vocal fold stellate cells contained in the human adult
maculae flavae were discovered in 2001.16 As described in
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detail previously, they are stellate in shape and possess
vitamin A storing lipid droplets, and are considered to be
a new category of cells in the human vocal fold.5,6,16,17
The question arises whether the vocal fold stellate cells
are tissue stem cells or progenitor cells (transit-
amplifying cells).10 However, at the present state of our
investigation, it is difficult to clarify the stem cell system
and hierarchy of stem cells in the human maculae flavae
and determine whether the vocal fold stellate cells are
putative stem cells or progenitor cells.
Likewise, Tateya et al. reported the cells in the rat
maculae flavae also have vitamin A storing lipid drop-
lets.18 However, at the present state of our investigation,
it is also difficult to clarify the stem cell system and hier-
archy of stem cells in the rat maculae flavae.
Stem Cell Niche in the Vocal Fold Mucosa
A stem cell niche is a specialized local microenviron-
ment where stem cells reside and which directly promote
maintenance of stem cells.19
Extracellular matrices are dynamic and complex
environments specific to each tissue which also regulate
cell behavior.20 Hyaluronan is one of the extracellular
matrix components and serves an important role for
numerous stem cell populations.21,22
Interactions between extracellular matrices and
stem cells can be mediated by cell receptors. CD44 is a
cell surface hyaluronan receptor, which has been found to
play an important role for hematopoietic stem cell
populations.23
The latest researches show, a hyaluronan-rich
matrix, composed of the glycosaminoglycan hyaluronan
and a cell surface receptor (CD44), is able to directly
affect the cellular functions of stem cells in a stem cell
niche.21,22
In the present study, label-retaining cells were sur-
rounded by a high concentration of hyaluronan and CD44
cell surface hyaluronan receptors were present in the cells
in the maculae flavae. This result suggests that the micro-
environment in the maculae flavae containing label-
retaining cells is a hyaluronan-rich matrix and the macula
flava is a candidate for a stem cell niche, that is, a microen-
vironment nurturing a pool of label-retaining cells.
Cell Origin in the Maculae Flavae
Circulating fibrocytes were first described by Bucala
et al.24 As described in detail previously, these cells have
been suggested to originate from bone marrow cells, cir-
culate into the blood streams and, after homing to the tis-
sue, differentiate into fibroblasts.25 The latest research
shows, CD34 (hematopoietic stem cell marker), CD45
(leukocyte common antigen) and Type I collagen are
major makers for circulating fibrocytes.25
In the present study, the cells in the maculae flavae
expressed hematopoietic markers (CD34, CD45) and Type
I collagen, which are the major makers for bone marrow
derived circulating fibrocytes. This result suggests the
cells in the maculae flavae arise not from resident
interstitial cells but from the differentiation of bone mar-
row cells.
Putative Stem Cells in the Vocal Fold Mucosa
In recent years, adult tissue stem cells which partici-
pate in tissue regeneration and repair, have been
detected in various organs.
Yamashita et al. reported side population cells, which
are considered to contain high numbers of stem cells or pro-
genitor cells, were identified in the anterior and posterior
maculae flavae in the human vocal fold mucosa.26
Gugatschka et al. reported side population cells in the ante-
rior and posterior maculae flavae participate in the early
stages of wound healing of the rat vocal fold.27
Kawai et al. reported on the distribution of slow-
cycling cells using label-retaining cell assay in the injured
rat vocal fold.28 According to this report, slow-cycling
cells, defined as double-labeling cells (immunohistochemi-
cally stained with BrdU and Ki-67) were identified in the
basal layer of the stratified squamous epithelium of the
injured rat vocal fold.28 Tateya et al. reported that there
were few BrdU-positive cells in the maculae flavae of the
injured rat vocal fold.29 Distribution of BrdU-positive
cells in the injured vocal fold model is different from the
normal one as shown in this study. Consequently, the
cells in the maculae flavae may migrate during the
wound healing process and may lose BrdU labeling in the
injured vocal fold.
Leydon et al. reported that label-retaining cells
(BrdU-positive cells) were present in the murine vocal
fold epithetium and the percentage of BrdU-positive cells
in the murine vocal fold epithelium decreased signifi-
cantly from 9.4% at 14 days to 3.1% at 56 days.30 In the
present study, the percentage of BrdU-positive cells in
the rat vocal fold epithelium also decreased significantly
from 18.8% at 14 days to 2.4% at 56 days. On the other
hand, the percentage of BrdU-positive cells in the rat
maculae flavae was high through day 56 (from 44.8% at
1 day to 41.4% at 14 days and to 33.3% at 56 days). Con-
sequently, label-retaining cells resided in the maculae fla-
vae of the vocal fold mucosa.
CONCLUSION
Label-retaining cells resided in the maculae flavae of
the vocal fold mucosa and maculae flavae had a
hyaluronan-rich matrix.
The results of this study are consistent with the
hypothesis that the maculae flavae are a candidate for a
stem cell niche and the cells in the maculae flavae are
putative stem cells of the vocal fold mucosa.
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